Your browser doesn't support javascript.
loading
Accuracy of central neuro-imaging review of DIPG compared with histopathology in the International DIPG Registry.
Lazow, Margot A; Fuller, Christine; DeWire, Mariko; Lane, Adam; Bandopadhayay, Pratiti; Bartels, Ute; Bouffet, Eric; Cheng, Sylvia; Cohen, Kenneth J; Cooney, Tabitha M; Coven, Scott L; Dholaria, Hetal; Diez, Blanca; Dorris, Kathleen; El-Ayadi, Moatasem; El-Sheikh, Ayman; Fisher, Paul G; Fonseca, Adriana; Garcia Lombardi, Mercedes; Greiner, Robert J; Goldman, Stewart; Gottardo, Nicholas; Gururangan, Sridharan; Hansford, Jordan R; Hassall, Tim; Hawkins, Cynthia; Kilburn, Lindsay; Koschmann, Carl; Leary, Sarah E; Ma, Jie; Minturn, Jane E; Monje-Deisseroth, Michelle; Packer, Roger; Samson, Yvan; Sandler, Eric S; Sevlever, Gustavo; Tinkle, Christopher L; Tsui, Karen; Wagner, Lars M; Zaghloul, Mohamed; Ziegler, David S; Chaney, Brooklyn; Black, Katie; Asher, Anthony; Drissi, Rachid; Fouladi, Maryam; Jones, Blaise V; Leach, James L.
Affiliation
  • Lazow MA; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Fuller C; Pediatric Neuro-Oncology Program, Nationwide Children's Hospital, Columbus, Ohio, USA.
  • DeWire M; The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Lane A; Department of Pathology, Upstate Medical University, Syracuse, New York, USA.
  • Bandopadhayay P; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Bartels U; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Bouffet E; Dana Farber Cancer Institute, Harvard Cancer Center, Boston, Massachusetts, USA.
  • Cheng S; Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cohen KJ; Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Cooney TM; Division of Pediatric Hematology/Oncology/BMT, British Columbia Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Coven SL; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA.
  • Dholaria H; Dana Farber Cancer Institute, Harvard Cancer Center, Boston, Massachusetts, USA.
  • Diez B; Division of Oncology, Riley Hospital for Children, Indianapolis, Indiana, USA.
  • Dorris K; Department of Oncology, Perth Children's Hospital, Nedlands, Australia.
  • El-Ayadi M; Department of Oncology and Pathology, Fundacion para la lucha de las enfermedades neurologicas de la infancia FLENI, Buenos Aires, Argentina.
  • El-Sheikh A; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Aurora, Colorado, USA.
  • Fisher PG; National Cancer Institute, Cairo University and Children's Cancer Hospital Egypt, Cairo, Egypt.
  • Fonseca A; Division of Oncology, Dayton Children's Hospital, Dayton, Ohio, USA.
  • Garcia Lombardi M; Department of Neurology, Stanford University, Stanford, California, USA.
  • Greiner RJ; Division of Oncology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Goldman S; Division of Oncology, Hospital de Ninos Ricardo Gutierrez, Buenos Aires, Argentina.
  • Gottardo N; Division of Oncology, Penn State Health Children's Hospital, Hershey, Pennsylvania, USA.
  • Gururangan S; Department of Pediatrics, Phoenix Children's Hospital, University of Arizona College of Medicine-Phoenix, Phoenix, Arizona, USA.
  • Hansford JR; Department of Oncology, Perth Children's Hospital, Nedlands, Australia.
  • Hassall T; Department of Neurosurgery, University of Florida, Gainsville, Florida, USA.
  • Hawkins C; Children's Cancer Centre, Royal Children's Hospital Murdoch Children's Research Institute University of Melbourne, Melbourne, Victoria, Australia.
  • Kilburn L; Division of Oncology, Queensland Children's Hospital, South Brisbane, Australia.
  • Koschmann C; Division of Pathology, The Hospital for Sick Children, Toronto, Ontario, Canada.
  • Leary SE; Division of Oncology, Children's National Medical Center, Washinton, District of Columbia, USA.
  • Ma J; Department of Pediatrics, University of Michigan, Ann Arbor, Michigan, USA.
  • Minturn JE; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, Washington, USA.
  • Monje-Deisseroth M; Division of Oncology, Xinhua Hospital, Shanghai, China.
  • Packer R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
  • Samson Y; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Sandler ES; Division of Oncology, Children's National Medical Center, Washinton, District of Columbia, USA.
  • Sevlever G; Division of Oncology, CHU Saint Justine, Montreal, Quebec, Canada.
  • Tinkle CL; Division of Oncology, Nemours Children's Health System, Wilmington, Delaware, USA.
  • Tsui K; Department of Oncology and Pathology, Fundacion para la lucha de las enfermedades neurologicas de la infancia FLENI, Buenos Aires, Argentina.
  • Wagner LM; Division of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Zaghloul M; Division of Oncology, Starship Children's Hospital, Auckland, New Zealand.
  • Ziegler DS; Division of Pediatric Hematology/Oncology, University of Kentucky, Lexington, Kentucky, USA.
  • Chaney B; National Cancer Institute, Cairo University and Children's Cancer Hospital Egypt, Cairo, Egypt.
  • Black K; School of Women's and Children's Health and Children's Cancer Institute, University of New South Wales, Sydney, Australia.
  • Asher A; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Drissi R; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Fouladi M; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
  • Jones BV; The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Leach JL; Center for Childhood Cancer & Blood Disorders, Nationwide Children's Hospital, Columbus, Ohio, USA.
Neuro Oncol ; 24(5): 821-833, 2022 05 04.
Article in En | MEDLINE | ID: mdl-34668975
ABSTRACT

BACKGROUND:

Diffuse intrinsic pontine glioma (DIPG) remains a clinico-radiologic diagnosis without routine tissue acquisition. Reliable imaging distinction between DIPG and other pontine tumors with potentially more favorable prognoses and treatment considerations is essential.

METHODS:

Cases submitted to the International DIPG registry (IDIPGR) with histopathologic and/or radiologic data were analyzed. Central imaging review was performed on diagnostic brain MRIs (if available) by two neuro-radiologists. Imaging features suggestive of alternative diagnoses included nonpontine origin, <50% pontine involvement, focally exophytic morphology, sharply defined margins, and/or marked diffusion restriction throughout.

RESULTS:

Among 286 patients with pathology from biopsy and/or autopsy, 23 (8%) had histologic diagnoses inconsistent with DIPG, most commonly nondiffuse low-grade gliomas and embryonal tumors. Among 569 patients with centrally-reviewed diagnostic MRIs, 40 (7%) were classified as non-DIPG, alternative diagnosis suspected. The combined analysis included 151 patients with both histopathology and centrally-reviewed MRI. Of 77 patients with imaging classified as characteristic of DIPG, 76 (99%) had histopathologic diagnoses consistent with DIPG (infiltrating grade II-IV gliomas). Of 57 patients classified as likely DIPG with some unusual imaging features, 55 (96%) had histopathologic diagnoses consistent with DIPG. Of 17 patients with imaging features suggestive of an alternative diagnosis, eight (47%) had histopathologic diagnoses inconsistent with DIPG (remaining patients were excluded due to nonpontine tumor origin). Association between central neuro-imaging review impression and histopathology was significant (p < 0.001), and central neuro-imaging impression was prognostic of overall survival.

CONCLUSIONS:

The accuracy and important role of central neuro-imaging review in confirming the diagnosis of DIPG is demonstrated.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Brain Stem Neoplasms / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Astrocytoma / Brain Stem Neoplasms / Glioma Type of study: Prognostic_studies Limits: Humans Language: En Journal: Neuro Oncol Journal subject: NEOPLASIAS / NEUROLOGIA Year: 2022 Document type: Article Affiliation country: United States